154 related articles for article (PubMed ID: 32678070)
21. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.
Yin H; Sheng Z; Zhang X; Du Y; Qin C; Liu H; Dun Y; Wang Q; Jin C; Zhao Y; Xu T
Oncol Rep; 2017 Feb; 37(2):1045-1051. PubMed ID: 27922675
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
24. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
[TBL] [Abstract][Full Text] [Related]
25. A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation.
Wang F; Zhang W; Song Z; Wang M; Wu H; Yang Y; Chen R
J Cancer Res Clin Oncol; 2021 Feb; 147(2):469-480. PubMed ID: 33221996
[TBL] [Abstract][Full Text] [Related]
26. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
[TBL] [Abstract][Full Text] [Related]
27. Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion.
Björkman M; Östling P; Härmä V; Virtanen J; Mpindi JP; Rantala J; Mirtti T; Vesterinen T; Lundin M; Sankila A; Rannikko A; Kaivanto E; Kohonen P; Kallioniemi O; Nees M
Oncogene; 2012 Jul; 31(29):3444-56. PubMed ID: 22120715
[TBL] [Abstract][Full Text] [Related]
28. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo.
Thomas C; Zoubeidi A; Kuruma H; Fazli L; Lamoureux F; Beraldi E; Monia BP; MacLeod AR; Thüroff JW; Gleave ME
Mol Cancer Ther; 2011 Feb; 10(2):347-59. PubMed ID: 21216933
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
32. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
[TBL] [Abstract][Full Text] [Related]
33. The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer.
Tian J; Zhang H; Mu L; Wang M; Li X; Zhang X; Xie E; Ma M; Wu D; Du Y
Exp Cell Res; 2020 Sep; 394(1):112128. PubMed ID: 32522441
[TBL] [Abstract][Full Text] [Related]
34. miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines.
Zhu C; Li J; Ding Q; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Qin C; Hua L; Shao P; Yin C
Prostate; 2013 Jul; 73(10):1082-9. PubMed ID: 23460133
[TBL] [Abstract][Full Text] [Related]
35. Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
Kurozumi A; Goto Y; Matsushita R; Fukumoto I; Kato M; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
Cancer Sci; 2016 Jan; 107(1):84-94. PubMed ID: 26509963
[TBL] [Abstract][Full Text] [Related]
36. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
37. Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis.
Shi J; Liu C; Chen C; Guo K; Tang Z; Luo Y; Chen L; Su Y; Xu K
Aging (Albany NY); 2020 Jul; 12(13):13255-13280. PubMed ID: 32645691
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
Guo Z; He C; Yang F; Qin L; Lu X; Wu J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration.
Khusbu FY; Zhou X; Roy M; Chen FZ; Cao Q; Chen HC
Int J Biochem Cell Biol; 2020 Jan; 118():105644. PubMed ID: 31712163
[TBL] [Abstract][Full Text] [Related]
40. HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer.
Rasiah KK; Gardiner-Garden M; Padilla EJ; Möller G; Kench JG; Alles MC; Eggleton SA; Stricker PD; Adamski J; Sutherland RL; Henshall SM; Hayes VM
Mol Cell Endocrinol; 2009 Mar; 301(1-2):89-96. PubMed ID: 19100308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
